BCL11A and breast carcinoma: By analyzing the correlation between gene expression and clinical characteristics in patients with malignant solid tumors, the expression of BCL11A was significantly confirmed to be positively correlated with some tumor metastases, such as breast cancer [20], liver cancer [21], laryngeal squamous cell carcinoma [22], lung squamous cell carcinoma [23], and so on.